Blood Pressure, White Matter Lesions and Medial Temporal Lobe Atrophy: Closing the Gap between Vascular Pathology and Alzheimer’s Disease?
暂无分享,去创建一个
Frederik Barkhof | Philip Scheltens | Frank-Erik de Leeuw | P. Scheltens | F. Barkhof | F. de Leeuw | E. Korf | Esther S.C. Korf
[1] Philip Scheltens,et al. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment , 2004, Neurology.
[2] Frederik Barkhof,et al. White matter lesions and hippocampal atrophy in Alzheimer’s disease , 2004, Neurology.
[3] P. Scheltens,et al. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability , 1995, Journal of Neurology.
[4] B. Siesjö,et al. The density and distribution of ischemic brain injury in the rat following 2–10 min of forebrain ischemia , 2004, Acta Neuropathologica.
[5] I. Skoog. Highs and lows of blood pressure: a cause of Alzheimer's disease? , 2003, The Lancet Neurology.
[6] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[7] L. Csiba,et al. Subcortical features and cognitive performance in Hungarian cerebrovascular outpatients , 2002, Journal of the Neurological Sciences.
[8] M. Albert,et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD , 2002, Neurology.
[9] L. Launer,et al. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.
[10] P. Scheltens,et al. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment , 2002, Journal of neurology, neurosurgery, and psychiatry.
[11] L. Launer. Demonstrating the case that AD is a vascular disease: epidemiologic evidence , 2002, Ageing Research Reviews.
[12] K. Meguro,et al. Five-year retrospective changes in hippocampal atrophy and cognitive screening test performances in very mild Alzheimer's disease: the Tajiri Project , 2002, Neuroradiology.
[13] D. Bennett,et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease☆ ☆ This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health. , 2001, Neurobiology of Aging.
[14] P. Luiten,et al. Cerebral microvascular pathology in aging and Alzheimer's disease , 2001, Progress in Neurobiology.
[15] J Tuomilehto,et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.
[16] P. Scheltens,et al. A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.
[17] A. Folsom,et al. Cardiovascular risk factors and cognitive decline in middle-aged adults , 2001, Neurology.
[18] Michael G. Hennerici,et al. Assessment of gait in subcortical vascular encephalopathy by computerized analysis: a cross-sectional and longitudinal study , 2000, Journal of Neurology.
[19] P Julin,et al. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study , 2000, Journal of neurology, neurosurgery, and psychiatry.
[20] M. Mishkin,et al. Developmental amnesia associated with early hypoxic-ischaemic injury. , 2000, Brain : a journal of neurology.
[21] W. Markesbery,et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS☆ , 2000, Neurobiology of Aging.
[22] R. Havlik,et al. Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.
[23] Philip Scheltens,et al. Visual assessment of medial temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry , 1999, Psychiatry Research: Neuroimaging.
[24] A. Pfeffer,et al. Magnetic Resonance Imaging-Based Hippocampal Volumetry in Patients with Dementia of the Alzheimer Type , 1999, Dementia and Geriatric Cognitive Disorders.
[25] C. Jack,et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.
[26] Cees Jonker,et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.
[27] D. Carmelli,et al. Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. , 1998, Stroke.
[28] J. Wegiel,et al. Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease , 1998, Brain Research.
[29] J. Widimský,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.
[30] R. D'Agostino,et al. NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study , 1997, Diabetes Care.
[31] D. Levy,et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.
[32] A. Hofman,et al. Non-insulin-dependent Diabetes Mellitus (niddm) Association of Diabetes Mellitus and Dementia: the Rotterdam Study , 2022 .
[33] B. Lernfelt,et al. 15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.
[34] E. Ringelstein,et al. Hyperinsulinism and cerebral microangiopathy. , 1996, Stroke.
[35] R. Havlik,et al. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.
[36] D. Sparks,et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension , 1995, Journal of the Neurological Sciences.
[37] M. Raskind,et al. Is Early‐Onset Alzheimer Disease a Distinct Subgroup Within the Alzheimer Disease Population? , 1995, Alzheimer disease and associated disorders.
[38] P. Scheltens,et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[39] P. Scheltens,et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. , 1992, Brain : a journal of neurology.
[40] K. Blennow,et al. White‐matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors , 1991, Acta neurologica Scandinavica.
[41] W. Jagust,et al. Alzheimer's disease. Age at onset and single-photon emission computed tomographic patterns of regional cerebral blood flow. , 1990, Archives of neurology.
[42] J. Haxby,et al. NIH conference. Alzheimer disease: clinical and biological heterogeneity. , 1988, Annals of internal medicine.
[43] L. Barclay,et al. Urinary and gait disturbances as markers for early multi-infarct dementia. , 1987, Stroke.
[44] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.